CA2291249A1 - Mild, leave-on antimicrobial compositions - Google Patents

Mild, leave-on antimicrobial compositions Download PDF

Info

Publication number
CA2291249A1
CA2291249A1 CA002291249A CA2291249A CA2291249A1 CA 2291249 A1 CA2291249 A1 CA 2291249A1 CA 002291249 A CA002291249 A CA 002291249A CA 2291249 A CA2291249 A CA 2291249A CA 2291249 A1 CA2291249 A1 CA 2291249A1
Authority
CA
Canada
Prior art keywords
leave
antimicrobial
composition
index
gram positive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002291249A
Other languages
French (fr)
Other versions
CA2291249C (en
Inventor
Peter William Beerse
Jeffrey Michael Morgan
Kathleen Grieshop Baier
Wei Cen
Theresa Anne Bakken
Mannie Lee Clapp
Raphael Warren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/967,972 external-priority patent/US6287577B1/en
Application filed by Individual filed Critical Individual
Publication of CA2291249A1 publication Critical patent/CA2291249A1/en
Application granted granted Critical
Publication of CA2291249C publication Critical patent/CA2291249C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a leave-on antimicrobial composition characterized in that it comprises from 0.001 % to 5 % of an antimicrobial active; from 0.05 % to 10 % of an anionic surfactant; from 0.1 %
to 10 % of a proton donating agent; and from 0 % to 99.85 % of water; wherein the composition is adjusted to a pH of from 3.0 to 6.0;
wherein the leave-on antimicrobial composition has a Gram Positive Residual Effectiveness Index of greater than 0.5; and wherein the leave-on antimicrobial composition has a Mildness Index of greater than 0.3. The present invention also relates to a leave-on antimicrobial cleansing composition which has a Gram Positive Residual Effectiveness Index of greater than 0.5. It also relates to a leave-on antimicrobial cleansing composition which has a One-wash Immediate Germ Reduction Index of greater than 1Ø The invention also encompasses methods for cleansing skin and providing residual effectiveness versus Gram positive bacteria using these products.
CA002291249A 1997-06-04 1998-05-29 Mild, leave-on antimicrobial compositions Expired - Fee Related CA2291249C (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US86930197A 1997-06-04 1997-06-04
US86930397A 1997-06-04 1997-06-04
US86871897A 1997-06-04 1997-06-04
US08/868,718 1997-06-04
US08/869,301 1997-06-04
US08/869,303 1997-06-04
US08/967,972 1997-11-12
US08/967,972 US6287577B1 (en) 1997-11-12 1997-11-12 Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria
PCT/US1998/010978 WO1998055081A2 (en) 1997-06-04 1998-05-29 Mild, leave-on antimicrobial compositions

Publications (2)

Publication Number Publication Date
CA2291249A1 true CA2291249A1 (en) 1998-12-10
CA2291249C CA2291249C (en) 2004-03-02

Family

ID=27505954

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002291249A Expired - Fee Related CA2291249C (en) 1997-06-04 1998-05-29 Mild, leave-on antimicrobial compositions

Country Status (10)

Country Link
EP (1) EP0996420A2 (en)
JP (1) JP2001518941A (en)
CN (1) CN1265028A (en)
AR (1) AR012240A1 (en)
AU (1) AU745392B2 (en)
BR (1) BR9811706A (en)
CA (1) CA2291249C (en)
CO (1) CO4940379A1 (en)
PE (1) PE79499A1 (en)
WO (1) WO1998055081A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413529B1 (en) 1999-04-13 2002-07-02 The Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria
US6482423B1 (en) * 1999-04-13 2002-11-19 The Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus gram positive bacteria
US6488943B1 (en) 1999-04-13 2002-12-03 The Procter & Gamble Company Antimicrobial wipes which provide improved immediate germ reduction
AU2001234509A1 (en) * 2000-01-20 2001-07-31 The Procter And Gamble Company Antimicrobial compositions
US6436885B2 (en) 2000-01-20 2002-08-20 The Procter & Gamble Company Antimicrobial cleansing compositions containing 2-pyrrolidone-5-carboxylic acid
FR2825618B1 (en) * 2001-06-07 2008-01-18 Oreal USE OF A POLAR ADDITIVE IN A COSMETIC COMPOSITION COMPRISING A LIQUID FATTY PHASE STRUCTURED BY AT LEAST ONE ORGANOGELER TO GIVE THE COMPOSITION A THIXOTROPIC CHARACTER
JP6324781B2 (en) * 2014-03-19 2018-05-16 花王株式会社 Disinfectant cleaning composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4026756C2 (en) * 1990-08-24 1995-03-23 Turner Gmbh Preservatives and their use
JPH06506938A (en) * 1991-04-15 1994-08-04 ザ、プロクター、エンド、ギャンブル、カンパニー Antibacterial mild liquid skin cleanser
DE69418465T2 (en) * 1993-07-03 1999-12-09 Procter & Gamble PERSONAL CLEANER
CN1145582A (en) * 1994-03-11 1997-03-19 普罗克特和甘保尔公司 Low pH, hydrolytically stable, cosmetic compsn. containing acidic actives
GB2288811B (en) * 1994-04-26 1998-07-15 Procter & Gamble Cleansing compositions
US5681802A (en) * 1994-06-01 1997-10-28 Lever Brothers Company, Division Of Conopco, Inc. Mild antimicrobial liquid cleansing formulations comprising buffering compound or compounds as potentiator of antimicrobial effectiveness
US5607980A (en) * 1995-07-24 1997-03-04 The Procter & Gamble Company Topical compositions having improved skin feel
DE69723430T2 (en) * 1996-05-02 2004-04-15 The Procter & Gamble Company, Cincinnati TOPICAL COMPOSITION WITH DISPERSED TENSIDE COMPLEX

Also Published As

Publication number Publication date
CN1265028A (en) 2000-08-30
PE79499A1 (en) 1999-10-15
CO4940379A1 (en) 2000-07-24
WO1998055081A2 (en) 1998-12-10
AU745392B2 (en) 2002-03-21
JP2001518941A (en) 2001-10-16
AR012240A1 (en) 2000-09-27
CA2291249C (en) 2004-03-02
EP0996420A2 (en) 2000-05-03
WO1998055081A3 (en) 1999-03-11
BR9811706A (en) 2000-07-25
AU7704898A (en) 1998-12-21

Similar Documents

Publication Publication Date Title
WO1998055080A3 (en) Leave-on antimicrobial compositions
MY122621A (en) Compositions containing a high percent saturation concentration of antibacterial agent
CA2260832A1 (en) Use of a combination of surfactants, chelating agents and essential oils for effective disinfection
NZ332864A (en) Skin wash composition comprising an alpha-hydroxy, salicyclic, maleic or pyruvic acid
WO2002019981A3 (en) Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use
BR0014778A (en) Antimicrobial Composition, Processes for Killing Bacteria, for Disabling Viruses, for Improving a Mammal's Global Health, for Reducing Absence of Persons, Use of Composition, Antimicrobial Product, and Personal Antimicrobial Treatment Set
MY129958A (en) Skin toning formulation
WO2003009802A3 (en) Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
IL123789A0 (en) Antimicrobial compositions containing a C3-C6 alcohol
PL328413A1 (en) Anticalculous tooth cleaning agent containing a well soluble pyrophosphate
PL317195A1 (en) Application of agents in the form of gel as dressing compositions
CA2275167A1 (en) The topical use of kappa opioid agonists to treat ocular pain
CA2291249A1 (en) Mild, leave-on antimicrobial compositions
WO2002005642A3 (en) Synergistic biocidal compositions
CA2293808A1 (en) Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
AU7941294A (en) Composition for the treatment or prevention of herpes
PL314799A1 (en) Application of dimeticone in treating constipations
AU1067795A (en) Use of lithium compounds in the treatment and prevention of alzheimer's disease
IT1271674B (en) Composition for cosmetic use including oligoelements
AU6750994A (en) Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
CA2177955A1 (en) Use of dimeticone for treating constipation
TH36749A (en) A mild antimicrobial mixture left over.
BG102974A (en) Ethene-containing solutions and their use in methods of treatment or prevention
CA2247907A1 (en) Skin toning formulation
CA2187314A1 (en) Binary active toilet bar composition

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed